News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlycoMimetics, Inc. (GLYC) To Present GMI-1271 Research Findings At American Association for Cancer Research Annual Meeting 2014


3/5/2014 9:34:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlycoMimetics, Inc. (NASDAQ:GLYC) announced today plans to present findings from research studies of its E-Selectin antagonist (GMI-1271) with three posters at the American Association for Cancer Research (AACR) Annual Meeting 2014. The posters will focus on the novel glycomimetic drug candidate’s potential as a treatment beyond hematological cancers to solid tumors (i.e., for breast cancer metastasis) as well as for its use in improving chemotherapy treatment. The AACR Annual Meeting 2014 will be held April 5-9 at the San Diego Convention Center.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES